Company Filing History:
3 out of 1,168 
1 out of 8 
1 out of 5 Years Active: 2007-2012
Title: Innovator Federica Damiani: Pioneering Advances in Mental Health Treatment
Introduction
Federica Damiani is a notable inventor based in Verona, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating mental disorders. With a total of four patents to her name, Damiani's work is recognized for its potential impact on mental health therapies.
Latest Patents
Among her latest patents, Damiani has developed novel compounds that exhibit affinity for the dopamine D3 receptor. These compounds, described by the formula (I) or its pharmaceutically acceptable salts, are particularly useful in treating mental disorders such as schizophrenia. The innovative nature of her work lies in the specific structural characteristics of these compounds, which include 5 or 6 membered heteroaromatic or heterocyclic rings.
Career Highlights
Throughout her career, Federica Damiani has worked with prominent organizations, including Glaxo Group Limited. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to drive innovation in mental health treatments.
Collaborations
Damiani has collaborated with esteemed colleagues such as Giorgio Bonanomi and Gabriella Gentile. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative compounds.
Conclusion
Federica Damiani's contributions to the field of mental health treatment through her patented innovations highlight her role as a leading inventor. Her work continues to pave the way for advancements in pharmaceutical therapies aimed at improving the lives of individuals with mental disorders.